NMPA Approval

Recombinant Human Brain Natriuretic Peptide for Injection

Approval Number

国药准字S20250019

Company苏州兰鼎生物制药有限公司

Registration Date

April 30, 2025

Drug Information

Generic Name

注射用重组人脑利钠肽

Dosage Form

注射剂

Strength

0.5mg（500 RU）/瓶

Drug Type

生物制品

Registration Date

April 30, 2025

Company Information

Applicant Company

Company Name苏州兰鼎生物制药有限公司

Company Address

苏州工业园区龙潭路118号

Manufacturing Company

Company Name苏州兰鼎生物制药有限公司

Company Address

苏州工业园区龙潭路118号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用重组人脑利钠肽 - NMPA 批准文号 | MedPath